Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.

Querol L, Siles AM, Alba-Rovira R, Jáuregui A, Devaux J, Faivre-Sarrailh C, Araque J, Rojas-Garcia R, Diaz-Manera J, Cortés-Vicente E, Nogales-Gadea G, Navas-Madroñal M, Gallardo E, Illa I.

Sci Rep. 2017 Oct 31;7(1):14411. doi: 10.1038/s41598-017-14853-4.

2.

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

Querol L, Nogales-Gadea G, Rojas-Garcia R, Martinez-Hernandez E, Diaz-Manera J, Suárez-Calvet X, Navas M, Araque J, Gallardo E, Illa I.

Ann Neurol. 2013 Mar;73(3):370-80. doi: 10.1002/ana.23794. Epub 2012 Dec 31.

PMID:
23280477
3.

Nodal proteins are target antigens in Guillain-Barré syndrome.

Devaux JJ, Odaka M, Yuki N.

J Peripher Nerv Syst. 2012 Mar;17(1):62-71. doi: 10.1111/j.1529-8027.2012.00372.x.

PMID:
22462667
4.

Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.

Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G.

J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):465-473. doi: 10.1136/jnnp-2016-314895. Epub 2017 Jan 10.

PMID:
28073817
5.

Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.

Doppler K, Appeltshauser L, Villmann C, Martin C, Peles E, Krämer HH, Haarmann A, Buttmann M, Sommer C.

Brain. 2016 Oct;139(Pt 10):2617-2630. Epub 2016 Jul 29.

PMID:
27474220
6.

Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.

Doppler K, Appeltshauser L, Krämer HH, Ng JK, Meinl E, Villmann C, Brophy P, Dib-Hajj SD, Waxman SG, Weishaupt A, Sommer C.

PLoS One. 2015 Jul 28;10(7):e0134274. doi: 10.1371/journal.pone.0134274. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137443.

7.

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.

Mathey EK, Garg N, Park SB, Nguyen T, Baker S, Yuki N, Yiannikas C, Lin CS, Spies JM, Ghaoui R, Barnett MH, Vucic S, Pollard JD, Kiernan MC.

J Neuroimmunol. 2017 Aug 15;309:41-46. doi: 10.1016/j.jneuroim.2017.05.002. Epub 2017 May 13.

PMID:
28601286
8.

Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies.

Labasque M, Hivert B, Nogales-Gadea G, Querol L, Illa I, Faivre-Sarrailh C.

J Biol Chem. 2014 Mar 14;289(11):7907-18. doi: 10.1074/jbc.M113.528489. Epub 2014 Feb 4.

9.

Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.

Doppler K, Stengel H, Appeltshauser L, Grosskreutz J, Man Ng JK, Meinl E, Sommer C.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1145-1151. doi: 10.1136/jnnp-2018-318170. Epub 2018 Jun 26.

PMID:
29945879
10.

Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.

Devaux JJ.

Am J Pathol. 2012 Oct;181(4):1402-13. doi: 10.1016/j.ajpath.2012.06.034. Epub 2012 Aug 10.

12.

Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.

Meléndez-Vásquez C, Redford J, Choudhary PP, Gray IA, Maitland P, Gregson NA, Smith KJ, Hughes RA.

J Neuroimmunol. 1997 Mar;73(1-2):124-34.

PMID:
9058768
13.

Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.

Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, Hughes RA.

J Peripher Nerv Syst. 2005 Jun;10(2):174-80.

PMID:
15958128
14.

Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.

Khalili-Shirazi A, Atkinson P, Gregson N, Hughes RA.

J Neuroimmunol. 1993 Jul;46(1-2):245-51.

PMID:
7689591
15.

Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.

Delmont E, Manso C, Querol L, Cortese A, Berardinelli A, Lozza A, Belghazi M, Malissart P, Labauge P, Taieb G, Yuki N, Illa I, Attarian S, Devaux JJ.

Brain. 2017 Jul 1;140(7):1851-1858. doi: 10.1093/brain/awx124.

PMID:
28575198
16.

Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.

Doppler K, Appeltshauser L, Wilhelmi K, Villmann C, Dib-Hajj SD, Waxman SG, Mäurer M, Weishaupt A, Sommer C.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):720-8. doi: 10.1136/jnnp-2014-309916. Epub 2015 Feb 18.

PMID:
25694474
17.

Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.

Siles AM, Martínez-Hernández E, Araque J, Diaz-Manera J, Rojas-Garcia R, Gallardo E, Illa I, Graus F, Querol L.

Ann Clin Transl Neurol. 2018 Mar 26;5(5):559-569. doi: 10.1002/acn3.554. eCollection 2018 May.

18.

Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy.

Sanvito L, Makowska A, Mahdi-Rogers M, Hadden RD, Peakman M, Gregson N, Nemni R, Hughes RA.

J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):333-8. doi: 10.1136/jnnp.2008.159798. Epub 2008 Nov 17.

PMID:
19015227
19.
20.

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, Sedano MJ, Gallardo E, Berciano J, Blesa R, Dalmau J, Illa I.

Neurology. 2014 Mar 11;82(10):879-86. doi: 10.1212/WNL.0000000000000205. Epub 2014 Feb 12.

Supplemental Content

Support Center